Advancing to first-in-human clinical trials requires formulation development to design a successful sterile formulation that ...

Mustang Bio has received orphan drug designation from the US Food and Drug Administration (FDA) for MB-108, a herpes simplex ...

Sonnet BioTherapeutics has announced the issuance of US Patent No. 12,134,635 covering its two new drug candidates, SON-1411 ...

Santen Pharmaceutical and Arctic Vision have signed a commercial collaboration agreement for the ARVN001to treat uveitic ...

Vidac will use the new funds to initiate a Phase IIb trial of its lead candidate VDA-1102 in patients with actinic keratosis.

Lord Vallance stated the government sees investment, innovation, and public-private partnership as crucial to UK healthcare.

With the boom in eClinical solutions showing no signs of slowing, adding a “human at the center” perspective can help ...

In value terms, ecommerce-related deal activity increased by 259900% in Q3 2024 compared with the previous quarter’s total of $0.5m and rose by 899% as compared to Q3 2023. Related deal volume ...

In Canada pharmaceutical industry, there were two private equity deals announced in Q3 2024, worth a total value of $4.2m, according to GlobalData's Deals Database.

In the global pharmaceutical industry, there were three private equity deals announced in Q3 2024, worth a total value of $4.2m, according to GlobalData's Deals Database.

Discover the top sales and marketing intelligence providers for the pharmaceutical industry, offering predictive insights and data enrichment to drive growth.

In the global pharmaceutical industry, there were two private equity deals announced in Q3 2024, worth a total value of $7.5m, according to GlobalData's Deals Database.